MedTrace Logo

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

NCT02054741 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 733

Last updated 2024-04-12

Study results available
· View outcomes & findings →

Summary

This cluster randomized clinical trial compares a geriatric assessment intervention with usual care for reducing cancer treatment toxicity in older patients with cancer that has spread to other places in the body. A geriatric assessment may identify risk factors for cancer treatment toxicity and may improve outcomes for older patients with advanced cancer.

Conditions

  • Adult Solid Neoplasm
  • Toxicity
  • Lymphoma

Interventions

OTHER

Comprehensive Geriatric Assessment

Complete geriatric assessment

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Survey Administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Chicago

    collaborator OTHER

  • City of Hope National Medical Center

    collaborator OTHER

  • Supriya Mohile

    lead OTHER

Principal Investigators

  • Supriya Mohile · University of Rochester NCORP Research Base

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-29
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02054741 on ClinicalTrials.gov